Cited by 42Alzheimer's disease research and treatmentsNeurogenesis and neuroplasticity mechanismsDementia and Cognitive Impairment Research

Dysregulated Expression of Monoacylglycerol Lipase Is a Marker for Anti-Diabetic Drug Metformin-Targeted Therapy to Correct Impaired Neurogenesis and Spatial Memory in Alzheimer’s Disease

Open access
Syal, Charvi, Kosaraju, Jayasankar, Hamilton, Laura, Aumont, Anne, Chu, Alphonse, Sarma, Sailendra Nath, Thomas, Jacob, Seegobin, Matthew +7 more·2020·Theranostics

Abstract

Our findings set the stage for development of a clinical protocol where Mgll would serve as a biomarker in early stages of AD to identify potential metformin-responsive AD patients to restore their neurogenesis and spatial memory.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7150/thno.44962

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Data indicate that metformin targets monoacylglycerol lipase, an enzyme responsible for generating pro-inflammatory eicosanoids from 2-arachidonoyl glycerol, providing potential to use metformin to treat Alzheimer's.

    “The potential to use metformin to treat Alzheimer’s is also provided by data indicating that metformin targets monoacylglycerol lipase, an enzyme responsible for generating pro-inflammatory eicosanoids from 2-arachidonoyl glycerol (258).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 1 · Cited by 42

Research works printed but not linked: 2

  1. [29]Koenig AM Mechanic-Hamilton D Xie SX Combs MF Cappola AR Xie L Effects of the insulin sensitizer metformin in Alzheimer disease: Pilot data from a randomized placebo-controlled crossover study Alzheimer Dis Assoc Disord 2017 31 107 13 28538088 PMC5476214
  2. [50]Grabner GF Eichmann TO Wagner B Gao Y Farzi A Taschler U Deletion of monoglyceride lipase in astrocytes attenuates lipopolysaccharide-induced neuroinflammation J Biol Chem 2016 291 913 23 26565024 PMC4705409

Authors
Syal, C., Kosaraju, J., Hamilton, L., Aumont, A., Chu, A., Sarma, S. N., Thomas, J., Seegobin, M., Dilworth, F. J., He, L., Wondisford, F. E., Zimmermann, R., Parent, M., Fernandes, K., & Wang, J.
Affiliations
  • University of Ottawa (CA)
  • Ottawa Hospital Research Institute (CA)
  • Université de Montréal (CA)
  • Johns Hopkins University (US)
  • Rutgers, The State University of New Jersey (US)
  • University of Graz (AT)
  • Université Laval (CA)
Corresponding author
Wang, Jing
Venue
Theranostics
Published
2020
Volume
10
Issue
14
Pages
6337-6360
ISSN
1838-7640 (ISSN-L)
OpenAlex
W3026217555
Cited by
42
References
1
Citations by year
2026: 2 · 2025: 2 · 2024: 16 · 2023: 7 · 2022: 10 · 2021: 5
FWCI
3.31
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Theranostics (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK107641, R01DK120309)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
monoacylglycerol lipase, monoglyceride lipase, metformin, Alzheimer's disease, neurogenesis, spatial memory, biomarkers, early Alzheimer's disease
MeSH terms
Alzheimer Disease, Animals, Disease Models, Animal, Female, Hippocampus, Humans, Hypoglycemic Agents, Male, Metformin, Mice, Transgenic, Monoacylglycerol Lipases, Protein Kinase C, Biomarkers, CREB-Binding Protein, Mice, Neurogenesis, Spatial Memory

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review